TY - GEN
T1 - Continuous Prompt for Chemical Language Model Aided Anticancer Synergistic Drug Combination Prediction
AU - Geng, Guannan
AU - Zhao, Lingling
AU - Wang, Chunyu
AU - Liu, Xiaoyan
AU - Wang, Junjie
N1 - Publisher Copyright:
© 2023 IEEE.
PY - 2023
Y1 - 2023
N2 - Identifying synergistic drug combinations is paramount significance in addressing complex diseases while reducing the risks of toxicities and other adverse effects. Although a plethora of computational methods have been proposed in this domain, most of them are underpinned only by physicochemical or biological features. Recently, Chemical Language Models (CLMs) are shown to be capable of learning better representations that hold utility across diverse tasks, from molecular property prediction, de novo drug design, drug-target interaction, and more. In this study, we proposed CLMSyn, a continuous prompt for CLM aided synergistic drug combinations prediction. Unlike existing works employ CLMs for downstream tasks, we adopt the prompt learning to fine-tune CLM, that is, only train small-scale prompt while keeping CLM fixed. Furthermore, we harness the the multi-head attention mechanism to fuse the learned vector from the CLM, chemical descriptors and gene expression of cell line. A comprehensive array of experiments conducted on a benchmark dataset, encompassing four distinct synergy types, substantiates the superior performance of CLMSyn when contrasted against existing state-of-the-art methods. These empirical findings provide compelling evidence attesting to the efficacy of CLMSyn as a potent instrumentality in expediting the identification of pioneering combination therapies.
AB - Identifying synergistic drug combinations is paramount significance in addressing complex diseases while reducing the risks of toxicities and other adverse effects. Although a plethora of computational methods have been proposed in this domain, most of them are underpinned only by physicochemical or biological features. Recently, Chemical Language Models (CLMs) are shown to be capable of learning better representations that hold utility across diverse tasks, from molecular property prediction, de novo drug design, drug-target interaction, and more. In this study, we proposed CLMSyn, a continuous prompt for CLM aided synergistic drug combinations prediction. Unlike existing works employ CLMs for downstream tasks, we adopt the prompt learning to fine-tune CLM, that is, only train small-scale prompt while keeping CLM fixed. Furthermore, we harness the the multi-head attention mechanism to fuse the learned vector from the CLM, chemical descriptors and gene expression of cell line. A comprehensive array of experiments conducted on a benchmark dataset, encompassing four distinct synergy types, substantiates the superior performance of CLMSyn when contrasted against existing state-of-the-art methods. These empirical findings provide compelling evidence attesting to the efficacy of CLMSyn as a potent instrumentality in expediting the identification of pioneering combination therapies.
KW - Chemical Language Model
KW - Drug Combination
KW - Multi-head Attention
KW - Prompt Learning
UR - https://www.scopus.com/pages/publications/85184985442
U2 - 10.1109/BigData59044.2023.10386652
DO - 10.1109/BigData59044.2023.10386652
M3 - 会议稿件
AN - SCOPUS:85184985442
T3 - Proceedings - 2023 IEEE International Conference on Big Data, BigData 2023
SP - 4406
EP - 4412
BT - Proceedings - 2023 IEEE International Conference on Big Data, BigData 2023
A2 - He, Jingrui
A2 - Palpanas, Themis
A2 - Hu, Xiaohua
A2 - Cuzzocrea, Alfredo
A2 - Dou, Dejing
A2 - Slezak, Dominik
A2 - Wang, Wei
A2 - Gruca, Aleksandra
A2 - Lin, Jerry Chun-Wei
A2 - Agrawal, Rakesh
PB - Institute of Electrical and Electronics Engineers Inc.
T2 - 2023 IEEE International Conference on Big Data, BigData 2023
Y2 - 15 December 2023 through 18 December 2023
ER -